Astera Labs (NASDAQ:ALAB) Stock Price Down 7.3% – Should You Sell?

Astera Labs, Inc. (NASDAQ:ALAB) shares traded down 7.3% on Monday . The stock traded as low as $210.02 and last traded at $215.58. 6,148,591 shares were traded during trading, an increase of 14% from the average session volume of 5,402,927 shares. The stock had previously closed at $232.68.

Analyst Upgrades and Downgrades

Several research firms have commented on ALAB. Royal Bank Of Canada boosted their target price on shares of Astera Labs from $250.00 to $270.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 6th. UBS Group started coverage on shares of Astera Labs in a research note on Tuesday, April 21st. They issued a “neutral” rating and a $180.00 price objective for the company. Needham & Company LLC increased their target price on shares of Astera Labs from $220.00 to $260.00 and gave the stock a “buy” rating in a research report on Wednesday, May 6th. Stifel Nicolaus boosted their price target on Astera Labs from $236.00 to $260.00 and gave the stock a “buy” rating in a research report on Wednesday, May 6th. Finally, Citigroup upped their price target on Astera Labs from $200.00 to $245.00 and gave the stock a “buy” rating in a research note on Wednesday, May 6th. Fifteen investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. Based on data from MarketBeat.com, Astera Labs presently has an average rating of “Moderate Buy” and an average price target of $229.65.

Astera Labs Stock Performance

The firm has a market capitalization of $36.95 billion, a price-to-earnings ratio of 145.66, a price-to-earnings-growth ratio of 3.08 and a beta of 3.35. The business’s 50 day moving average is $155.40 and its 200-day moving average is $156.31.

Astera Labs (NASDAQ:ALAB) last released its earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. The firm had revenue of $308.36 million during the quarter, compared to analyst estimates of $292.19 million. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The business’s revenue was up 93.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Equities research analysts forecast that Astera Labs, Inc. will post 1.84 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, CEO Jitendra Mohan sold 325,693 shares of the stock in a transaction that occurred on Friday, April 17th. The stock was sold at an average price of $172.14, for a total transaction of $56,064,793.02. Following the completion of the sale, the chief executive officer owned 4,079,322 shares in the company, valued at $702,214,489.08. This represents a 7.39% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 230,639 shares of the firm’s stock in a transaction that occurred on Thursday, May 7th. The shares were sold at an average price of $198.22, for a total value of $45,717,262.58. Following the completion of the sale, the chief operating officer directly owned 664,361 shares in the company, valued at $131,689,637.42. This trade represents a 25.77% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 1,497,338 shares of company stock worth $236,827,957 over the last quarter. 12.50% of the stock is currently owned by company insiders.

Institutional Trading of Astera Labs

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Riposte Capital LLC acquired a new stake in Astera Labs during the first quarter worth about $6,576,000. Empowered Funds LLC increased its stake in Astera Labs by 5.1% in the first quarter. Empowered Funds LLC now owns 9,606 shares of the company’s stock valued at $1,053,000 after acquiring an additional 462 shares during the period. The Manufacturers Life Insurance Company raised its position in Astera Labs by 79.8% in the first quarter. The Manufacturers Life Insurance Company now owns 538,205 shares of the company’s stock worth $58,987,000 after purchasing an additional 238,911 shares in the last quarter. Estuary Capital Management LP bought a new position in Astera Labs during the first quarter worth about $18,737,000. Finally, Quantinno Capital Management LP lifted its position in shares of Astera Labs by 49.8% during the 1st quarter. Quantinno Capital Management LP now owns 42,150 shares of the company’s stock worth $4,620,000 after buying an additional 14,010 shares during the period. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.